Ambica Agarbathies Aroma & Industries Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
Ambica Agarbathies Aroma & Industries's earnings have been declining at an average annual rate of -57.3%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been declining at an average rate of 9.9% per year.
Wichtige Informationen
-57.3%
Wachstumsrate der Gewinne
-57.1%
EPS-Wachstumsrate
| Chemicals Wachstum der Industrie | 17.7% |
| Wachstumsrate der Einnahmen | -9.9% |
| Eigenkapitalrendite | -0.9% |
| Netto-Marge | -0.9% |
| Letzte Ertragsaktualisierung | 30 Jun 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Aufschlüsselung der Einnahmen und Ausgaben
Wie Ambica Agarbathies Aroma & Industries Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 24 | 996 | -9 | 49 | 0 |
| 31 Mar 24 | 978 | -37 | 79 | 0 |
| 31 Dec 23 | 1,097 | -21 | 79 | 0 |
| 30 Sep 23 | 1,127 | 3 | 73 | 0 |
| 30 Jun 23 | 1,176 | 29 | 30 | 0 |
| 31 Mar 23 | 1,172 | 25 | 69 | 0 |
| 31 Dec 22 | 1,225 | 23 | 56 | 0 |
| 30 Sep 22 | 1,193 | 9 | 57 | 0 |
| 30 Jun 22 | 1,181 | 4 | 55 | 0 |
| 31 Mar 22 | 1,163 | 24 | 55 | 0 |
| 31 Dec 21 | 1,146 | 44 | 51 | 0 |
| 30 Sep 21 | 1,157 | 36 | 35 | 0 |
| 30 Jun 21 | 1,249 | 28 | 40 | 0 |
| 31 Mar 21 | 1,434 | 27 | 65 | 0 |
| 31 Dec 20 | 1,727 | 20 | 85 | 0 |
| 30 Sep 20 | 1,765 | 2 | 90 | 0 |
| 30 Jun 20 | 1,724 | 10 | 92 | 0 |
| 31 Mar 20 | 1,675 | 43 | 95 | 0 |
| 31 Dec 19 | 1,518 | 87 | 95 | 0 |
| 30 Sep 19 | 1,481 | 129 | 92 | 0 |
| 30 Jun 19 | 1,428 | 130 | 52 | 0 |
| 31 Mar 19 | 1,382 | 102 | 92 | 0 |
| 31 Dec 18 | 1,275 | -158 | 88 | 0 |
| 30 Sep 18 | 1,267 | -175 | 83 | 0 |
| 30 Jun 18 | 1,268 | -178 | 51 | 0 |
| 31 Mar 18 | 1,254 | -178 | 76 | 0 |
| 31 Dec 17 | 1,214 | 11 | 49 | 0 |
| 30 Sep 17 | 1,208 | 16 | 52 | 0 |
| 30 Jun 17 | 1,192 | 15 | 55 | 0 |
| 31 Mar 17 | 1,192 | 15 | 60 | 0 |
| 31 Dec 16 | 1,101 | 11 | 84 | 0 |
| 30 Sep 16 | 1,138 | 13 | 85 | 0 |
| 30 Jun 16 | 1,143 | 13 | 86 | 0 |
| 31 Mar 16 | 1,158 | 13 | 86 | 0 |
| 31 Dec 15 | 1,137 | 22 | 75 | 0 |
| 30 Sep 15 | 1,125 | 12 | 42 | 0 |
| 30 Jun 15 | 1,150 | 14 | 41 | 0 |
| 31 Mar 15 | 1,157 | 14 | 72 | 0 |
| 31 Dec 14 | 1,150 | 15 | 37 | 0 |
| 30 Sep 14 | 1,157 | 11 | 32 | 0 |
| 30 Jun 14 | 1,141 | 14 | 32 | 0 |
| 31 Mar 14 | 1,120 | 11 | 61 | 0 |
| 31 Dec 13 | 1,108 | 4 | 209 | 0 |
Qualität der Erträge: 532335 is currently unprofitable.
Wachsende Gewinnspanne: 532335 is currently unprofitable.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 532335 is unprofitable, and losses have increased over the past 5 years at a rate of 57.3% per year.
Beschleunigtes Wachstum: Unable to compare 532335's earnings growth over the past year to its 5-year average as it is currently unprofitable
Erträge im Vergleich zur Industrie: 532335 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (10.4%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 532335 has a negative Return on Equity (-0.91%), as it is currently unprofitable.